Free Trial

Phreesia Q2 2025 Earnings Report

Phreesia logo
$28.47 -0.53 (-1.81%)
As of 01/31/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Phreesia EPS Results

Actual EPS
-$0.31
Consensus EPS
-$0.37
Beat/Miss
Beat by +$0.06
One Year Ago EPS
N/A

Phreesia Revenue Results

Actual Revenue
$102.12 million
Expected Revenue
$101.76 million
Beat/Miss
Beat by +$360.00 thousand
YoY Revenue Growth
N/A

Phreesia Announcement Details

Quarter
Q2 2025
Time
N/A

Conference Call Resources

Phreesia Earnings Headlines

Phreesia price target raised to $33 from $31 at Piper Sandler
Elon’s #1 AI Stock” SET TO SOAR
Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.
Phreesia management to meet with Piper Sandler
Truist Financial Issues a Buy Rating on Phreesia (PHR)
Phreesia’s Growth Potential and Balanced Strategy Justifies Buy Rating
See More Phreesia Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Phreesia? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Phreesia and other key companies, straight to your email.

About Phreesia

Phreesia (NYSE:PHR) provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

View Phreesia Profile

More Earnings Resources from MarketBeat